Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katrin Anne Becker

Showing results (41-50 of 82) with videos related to

Pageof 9
Sort By:
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|April 13, 2019
Signalling Effects Induced by Acid Ceramidase in Human Epithelial Or Leukemic Cell LinesKäthe Baduva, Lara Büchter, Katja Kreyenkamp, et al.
Journal of Molecular Medicine (Berlin, Germany)|May 29, 2023
Acid sphingomyelinase expression is associated with survival in resectable pancreatic ductal adenocarcinomaGregory C Wilson, Sameer H Patel, Jiang Wang, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|May 18, 2016
Lack of Sphingosine Causes Susceptibility to Pulmonary Staphylococcus Aureus Infections in Cystic FibrosisShaghayegh Tavakoli Tabazavareh, Aaron Seitz, Peter Jernigan, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|October 17, 2017
Regulation of Arthritis Severity by the Acid SphingomyelinaseNadine Beckmann, Katrin Anne Becker, Silke Walter, et al.
Neuro-Signals|November 29, 2019
Pharmacological Inhibition of Acid Sphingomyelinase Ameliorates Experimental Autoimmune EncephalomyelitisSilke Walter, Erich Gulbins, Ramona Halmer, et al.
International Journal of Molecular Sciences|December 15, 2019
Acid Sphingomyelinase Deficiency Ameliorates Farber DiseaseNadine Beckmann, Katrin Anne Becker, Stephanie Kadow, et al.
Journal of Lipid Research|March 12, 2020
Characterization of the small molecule ARC39, a direct and specific inhibitor of acid sphingomyelinase in vitroEyad Naser, Stephanie Kadow, Fabian Schumacher, et al.
Molecular Psychiatry|November 27, 2021
Comorbid medical conditions are a key factor to understand the relationship between psychiatric disorders and COVID-19-related mortality: Results from 49,089 COVID-19 inpatientsNicolas Hoertel, Marina Sánchez-Rico, Juan José Herrera-Morueco, et al.
Infection and Immunity|November 3, 2020
Acid Ceramidase Rescues Cystic Fibrosis Mice from Pulmonary InfectionsKatrin Anne Becker, Rabea Verhaegh, Hedda-Luise Verhasselt, et al.
Molecular Psychiatry|August 13, 2021
Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19: current evidence and potential mechanismsNicolas Hoertel, Marina Sánchez-Rico, Céline Cougoule, et al.
Pageof 9

Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|April 13, 2019
Signalling Effects Induced by Acid Ceramidase in Human Epithelial Or Leukemic Cell LinesKäthe Baduva, Lara Büchter, Katja Kreyenkamp, et al.
Journal of Molecular Medicine (Berlin, Germany)|May 29, 2023
Acid sphingomyelinase expression is associated with survival in resectable pancreatic ductal adenocarcinomaGregory C Wilson, Sameer H Patel, Jiang Wang, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|May 18, 2016
Lack of Sphingosine Causes Susceptibility to Pulmonary Staphylococcus Aureus Infections in Cystic FibrosisShaghayegh Tavakoli Tabazavareh, Aaron Seitz, Peter Jernigan, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|October 17, 2017
Regulation of Arthritis Severity by the Acid SphingomyelinaseNadine Beckmann, Katrin Anne Becker, Silke Walter, et al.
Neuro-Signals|November 29, 2019
Pharmacological Inhibition of Acid Sphingomyelinase Ameliorates Experimental Autoimmune EncephalomyelitisSilke Walter, Erich Gulbins, Ramona Halmer, et al.
International Journal of Molecular Sciences|December 15, 2019
Acid Sphingomyelinase Deficiency Ameliorates Farber DiseaseNadine Beckmann, Katrin Anne Becker, Stephanie Kadow, et al.
Journal of Lipid Research|March 12, 2020
Characterization of the small molecule ARC39, a direct and specific inhibitor of acid sphingomyelinase in vitroEyad Naser, Stephanie Kadow, Fabian Schumacher, et al.
Molecular Psychiatry|November 27, 2021
Comorbid medical conditions are a key factor to understand the relationship between psychiatric disorders and COVID-19-related mortality: Results from 49,089 COVID-19 inpatientsNicolas Hoertel, Marina Sánchez-Rico, Juan José Herrera-Morueco, et al.
Infection and Immunity|November 3, 2020
Acid Ceramidase Rescues Cystic Fibrosis Mice from Pulmonary InfectionsKatrin Anne Becker, Rabea Verhaegh, Hedda-Luise Verhasselt, et al.
Molecular Psychiatry|August 13, 2021
Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19: current evidence and potential mechanismsNicolas Hoertel, Marina Sánchez-Rico, Céline Cougoule, et al.
Pageof 9